Targeted ablation, silencing, and activation establish glycinergic dorsal horn neurons as key components of a spinal gate for pain and itch

Neuron
Edmund FosterHanns Ulrich Zeilhofer

Abstract

The gate control theory of pain proposes that inhibitory neurons of the spinal dorsal horn exert critical control over the relay of nociceptive signals to higher brain areas. Here we investigated how the glycinergic subpopulation of these neurons contributes to modality-specific pain and itch processing. We generated a GlyT2::Cre transgenic mouse line suitable for virus-mediated retrograde tracing studies and for spatially precise ablation, silencing, and activation of glycinergic neurons. We found that these neurons receive sensory input mainly from myelinated primary sensory neurons and that their local toxin-mediated ablation or silencing induces localized mechanical, heat, and cold hyperalgesia; spontaneous flinching behavior; and excessive licking and biting directed toward the corresponding skin territory. Conversely, local pharmacogenetic activation of the same neurons alleviated neuropathic hyperalgesia and chloroquine- and histamine-induced itch. These results establish glycinergic neurons of the spinal dorsal horn as key elements of an inhibitory pain and itch control circuit.

References

Sep 2, 1985·Life Sciences·C BeyerB R Komisaruk
Nov 19, 1965·Science·R Melzack, P D Wall
Mar 3, 1995·Neuroscience Letters·D R SimmonsA J Todd
Dec 5, 1997·Brain Research. Molecular Brain Research·I PoyatosF Zafra
Jun 10, 2000·Science·C J Woolf, M W Salter
Dec 22, 2004·The Journal of Comparative Neurology·Hanns Ulrich ZeilhoferJean-Marc Fritschy
Aug 12, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Joachim ScholzClifford J Woolf
Feb 10, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Carole Torsney, Amy B MacDermott
Mar 21, 2006·European Journal of Pain : EJP·Anna K ClarkMarzia Malcangio
Mar 6, 2007·Brain Research·Mehdi HossainiJan C Holstege
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Blaine N ArmbrusterBryan L Roth
Oct 30, 2007·Nature Neuroscience·Uwe-Karsten Hanisch, Helmut Kettenmann
Jul 11, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Deniz AtasoyScott M Sternson
Feb 27, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Loïs S MiraucourtDaniel L Voisin
Apr 4, 2009·Physiological Reviews·Jürgen Sandkühler
Jun 23, 2009·Nature Reviews. Neuroscience·Martyn Goulding
Oct 16, 2010·Nature Medicine·Rohini Kuner
Feb 16, 2011·Human Gene Therapy·J Nicholas Betley, Scott M Sternson
Oct 25, 2011·Neuron·Jeffry S Isaacson, Massimo Scanziani
Feb 3, 2012·Physiological Reviews·Hanns Ulrich ZeilhoferGonzalo E Yévenes
May 16, 2012·The Journal of Experimental Medicine·Wei XiongLi Zhang

❮ Previous
Next ❯

Citations

Jan 20, 2016·Pain·Rafael MaldonadoDavid Cabañero
Oct 31, 2015·Science·Steeve BouraneMartyn Goulding
Mar 20, 2015·Neuron·Jing Zhao, John N Wood
Apr 4, 2016·European Journal of Pharmacology·Garrett L CornelisonS John Mihic
Aug 21, 2015·Neuron·Vijayan Gangadharan, Rohini Kuner
Sep 4, 2015·The Journal of Dermatology·Masutaka Furue, Takafumi Kadono
May 21, 2015·Pain·Hanns Ulrich Zeilhofer, Martin Schmelz
May 6, 2016·Science Translational Medicine·Kate L MontgomeryScott L Delp
Jun 9, 2016·The Journal of Clinical Investigation·Mario A AcuñaHanns Ulrich Zeilhofer
Sep 3, 2016·The Journal of Pain : Official Journal of the American Pain Society·Daniel VardehClifford J Woolf
Oct 27, 2016·Neuroscience·Matilde Cordero-ErausquinSylvain Hugel
Oct 30, 2016·Trends in Immunology·Felipe A Pinho-RibeiroIsaac M Chiu
Nov 3, 2016·Cell Reports·Amelia J ChristensenScott L Delp
Dec 20, 2016·Nature Structural & Molecular Biology·Xin HuangJacinthe Gingras
Dec 20, 2016·ELife·Junichi HachisukaSarah E Ross
Feb 25, 2017·The Journal of Allergy and Clinical Immunology·Ferda CevikbasAllan I Basbaum
Dec 16, 2016·Nature Reviews. Neuroscience·Rohini Kuner, Herta Flor
Jan 12, 2017·Brain : a Journal of Neurology·Filippo Martinelli-BoneschiGiuseppe Lauria
Apr 1, 2016·Molecular Pain·Robert P BoninYves De Koninck
Jun 27, 2017·The Journal of Comparative Neurology·May TranAllan I Basbaum
Mar 21, 2018·Nature Neuroscience·Jing HuangMark A Hoon
Jan 30, 2018·Frontiers in Molecular Neuroscience·Anja ArmbrusterVolker Eulenburg
Oct 24, 2017·Nature·Paolo CapelliSilvia Arber
Nov 18, 2017·Brain : a Journal of Neurology·Pascal Henri VuilleumierMichele Curatolo
Oct 6, 2016·Development·Helen C LaiJane E Johnson
Jun 13, 2018·The Journal of Clinical Investigation·Ming-Dong ZhangTomas Hökfelt
Sep 12, 2018·Journal of Neurochemistry·Li WangHui-Lin Pan
Dec 18, 2018·JAMA Neurology·Karlo J LizarragaAnthony E Lang
Aug 28, 2018·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Changming WangZongxiang Tang

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic

Software Mentioned

ImageJ

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Amyloidogenesis-associated Polyneuropathy

Amyloid deposits around nerves can damage and disrupt smooth information processing between the brain and organs. Here is the latest research on amyloidosis-associated polyneuropathies.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Brain developing: Influences & Outcomes

This feed focuses on influences that affect the developing brain including genetics, fetal development, prenatal care, and gene-environment interactions. Here is the latest research in this field.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.